Metropolitan Life Insurance Company (MetLife)’s BeOne Medicines Ltd ONC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,800	Closed	-$516K	–	2580
2020 Q3	$516K	Sell	1,800 -200	-10%	-$47K	0.01%	1198
2020 Q2	$377K	Buy	2,000 +300	+18%	+$48.8K	0.01%	1410
2020 Q1	$209K	Hold	1,700	–	–	﹤0.01%	1564
2019 Q4	$282K	Hold	1,700	–	–	﹤0.01%	1680
2019 Q3	$208K	Buy	1,700 +200	+13%	+$26.6K	﹤0.01%	1849
2019 Q2	$186K	Hold	1,500	–	–	﹤0.01%	1938
2019 Q1	$198K	Buy	1,500 +500	+50%	+$67.5K	﹤0.01%	1906
2018 Q4	$140K	Buy	+1,000	New	+$133K	﹤0.01%	2055

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ONC Position: Q4 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 1,800 shares — an estimated $516K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ONC in Q4 2018 and held it in 8 quarters. The position peaked at $516K in Q3 2020. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

Metropolitan Life Insurance Company (MetLife) reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,800 BeOne Medicines Ltd shares in Q4 2020, an estimated $516K.
Metropolitan Life Insurance Company (MetLife) first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 8 quarters.
Metropolitan Life Insurance Company (MetLife)'s BeOne Medicines Ltd position peaked at $516K in Q3 2020.
248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.